Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacology of rasagiline (N-propargyl-1R-aminoindan).

× No keyword cloud information.

15 in total

1. Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.

Authors: Keiko Inaba-Hasegawa; Yukihiro Akao; Wakako Maruyama; Makoto Naoi
Journal: J Neural Transm (Vienna) Date: 2011-11-08 Impact factor: 3.575

2. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.

Authors: M B Youdim; A Gross; J P Finberg
Journal: Br J Pharmacol Date: 2001-01 Impact factor: 8.739

Review 3. Rasagiline.

Authors: M Asif A Siddiqui; Greg L Plosker
Journal: Drugs Aging Date: 2005 Impact factor: 3.923

4. Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.

Authors: I Lamensdorf; S Porat; R Simantov; J P Finberg
Journal: Br J Pharmacol Date: 1999-02 Impact factor: 8.739

5. Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline.

Authors: Zaid A Abassi; Ofer Binah; Moussa B H Youdim
Journal: Br J Pharmacol Date: 2004-08-31 Impact factor: 8.739

6. Spotlight on rasagiline in Parkinson's disease.

Authors: Vicki Oldfield; Gillian M Keating; Caroline M Perry
Journal: CNS Drugs Date: 2008 Impact factor: 5.749

Review 7. Neuroprotective strategies in Parkinson's disease : an update on progress.

Authors: Silvia Mandel; Edna Grünblatt; Peter Riederer; Manfred Gerlach; Yona Levites; Moussa B H Youdim
Journal: CNS Drugs Date: 2003 Impact factor: 5.749

Review 8. Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway.

Authors: Silvia A Mandel; Yotam Sagi; Tamar Amit
Journal: Neurochem Res Date: 2007-08-16 Impact factor: 3.996

Review 9. Rasagiline: a review of its use in the management of Parkinson's disease.

Authors: Vicki Oldfield; Gillian M Keating; Caroline M Perry
Journal: Drugs Date: 2007 Impact factor: 9.546

Review 10. Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs.

Authors: Orly Weinreb; Silvia Mandel; Orit Bar-Am; Merav Yogev-Falach; Yael Avramovich-Tirosh; Tamar Amit; Moussa B H Youdim
Journal: Neurotherapeutics Date: 2009-01 Impact factor: 7.620